Your session is about to expire
← Back to Search
Storybook Reading for Language Disorder (KAWStory Trial)
N/A
Recruiting
Led By Holly Storkel
Research Sponsored by University of Kansas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 5-6 years
Normal hearing
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 20 weeks: pre-treatment, treatment (7.5 weeks), 12-weeks post-treatment
Awards & highlights
KAWStory Trial Summary
This trial is testing a storybook reading treatment to help Kindergarten children with SLI learn new words, by varying how often they are asked to talk about the words they are learning.
Who is the study for?
This trial is for kindergarten children aged 5-6 with Specific Language Impairment (SLI). They must be eligible for kindergarten, have normal hearing and nonverbal IQ of 85 or higher. Children should have a documented language impairment and vocabulary impairment based on specific test scores. Bilingual children or those with neurological disorders like autism are excluded.Check my eligibility
What is being tested?
The study tests three methods of interactive storybook reading to help kids with SLI learn new words. The methods differ in how often the children are asked about the words they're learning: low, medium, or high frequency testing. The goal is to see which method improves word learning and retention best.See study design
What are the potential side effects?
Since this intervention involves educational activities without medical treatments, there aren't typical side effects as seen in drug trials. However, some children might experience frustration or fatigue during frequent testing sessions.
KAWStory Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 5 and 6 years old.
Select...
I have normal hearing.
KAWStory Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 20 weeks: pre-treatment, treatment (7.5 weeks), 12-weeks post-treatment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~20 weeks: pre-treatment, treatment (7.5 weeks), 12-weeks post-treatment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in definition scores from pre- to 12-weeks post-treatment
Secondary outcome measures
Change in naming scores from pre- to 12-weeks post-treatment
Other outcome measures
Change in untaught vocabulary
KAWStory Trial Design
3Treatment groups
Experimental Treatment
Group I: Mid TestingExperimental Treatment1 Intervention
Children will receive 2 testing (talking) exposures and 4 listening exposures for a total of 6 exposures to each word. This is a listening and talking condition with mostly listening.
Group II: Low TestingExperimental Treatment1 Intervention
Children will receive 0 testing (talking) exposures and 6 listening exposures for a total of 6 exposures to each word. This is a listening only condition with minimal testing.
Group III: High TestingExperimental Treatment1 Intervention
Children will receive 4 testing (talking) exposures and 2 listening exposures for a total of 6 exposures to each word. This is a listening and talking condition with mostly talking.
Find a Location
Who is running the clinical trial?
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
328 Previous Clinical Trials
178,236 Total Patients Enrolled
University of KansasLead Sponsor
147 Previous Clinical Trials
325,801 Total Patients Enrolled
Holly StorkelPrincipal InvestigatorUniversity of Kansas
1 Previous Clinical Trials
35 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have normal hearing.I am of age to start kindergarten.I am between 5 and 6 years old.I do not have a neurological condition like autism that would explain my speech and language issues.You have a documented language score of 94 or lower on SPELT-3, or 91 or lower on TNL-2.Your nonverbal IQ is 85 or higher.You have trouble understanding and using words, as shown by certain test scores.
Research Study Groups:
This trial has the following groups:- Group 1: Low Testing
- Group 2: Mid Testing
- Group 3: High Testing
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many participants are being monitored in this research endeavor?
"Indeed, the clinicaltrials.gov website shows that this study is in need of participants and has been open since July 2nd 2018. The last update was on April 1st 2022, and it requires 60 patients at a single site for completion."
Answered by AI
Who might be considered the ideal candidates for this clinical investigation?
"This investigation is recruiting 60 five or six year-olds with a speech delay. The children must be qualified for kindergarten, have normal hearing and cognitive ability (as demonstrated by nonverbal IQ of 85+), language impairment as indicated by SPELT-3/ TNL-2 scores (both less than 94) and lexical deficiency evidenced by DELV/ CELF 4 Word Classes /CCC 2 results (all below 6)."
Answered by AI
Does this research study have any upper age limit for participants?
"As per the set parameters of this clinical trial, it is open to participants who are between 5 and 6 years old. Additionally, 18 trials are available for those under legal age while one can be accessed by seniors."
Answered by AI
Is access to this trial currently available for participants?
"According to clinicaltrials.gov, this research study is actively searching for participants and has been listed since July 2nd 2018; the listing was last edited on April 1st 2022."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger